Short-term ocular tolerability of dorzolamide 2% and brinzolamide 1% vs placebo in primary open-angle glaucoma and ocular hypertension subjects

被引：0
|
作者：
W C Stewart
D G Day
J A Stewart
K T Holmes
J N Jenkins
机构：
[1] Pharmaceutical Research Network,
[2] LLC,undefined
[3] Carolina Eye Institute at the University of South Carolina,undefined
[4] School of Medicine,undefined
[5] Atlanta Research Company,undefined
来源：
Eye | 2004年 / 18卷
关键词：
ocular tolerability; dorzolamide; brinzolamide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose To compare ocular tolerability of dorzolamide 2%, brinzolamide 1%, and placebo given three times daily.
引用
收藏
页码：905 / 910
页数：5
相关论文
共 50 条
  • [21] Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension
    Teus, Miguel A.
    Miglior, Stefano
    Laganovska, Guna
    Volksone, Lasma
    Romanowska-Dixon, Bozena
    Gos, Roman
    Hollo, Gabor
    CLINICAL OPHTHALMOLOGY, 2009, 3 : 629 - 636
  • [22] Pulsatile ocular blood flow in primary open-angle glaucoma and ocular hypertension
    Kerr, A
    Nelson, P
    O'brien, C
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (06) : 1106 - 1113
  • [23] Randomized Trial of Brinzolamide/Brimonidine Versus Brinzolamide Plus Brimonidine for Open-Angle Glaucoma or Ocular Hypertension
    Gandolfi, Stefano A.
    Lim, John
    Cristina Sanseau, Ana
    Parra Restrepo, Juan Camilo
    Hamacher, Thomas
    ADVANCES IN THERAPY, 2014, 31 (12) : 1213 - 1227
  • [24] Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension
    Michaud, JE
    Friren, B
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2001, 132 (02) : 235 - 243
  • [25] Randomized Trial of Brinzolamide/Brimonidine Versus Brinzolamide Plus Brimonidine for Open-Angle Glaucoma or Ocular Hypertension
    Stefano A. Gandolfi
    John Lim
    Ana Cristina Sanseau
    Juan Camilo Parra Restrepo
    Thomas Hamacher
    Advances in Therapy, 2014, 31 : 1213 - 1227
  • [26] Brinzolamide/Brimonidine: A Review of Its Use in Patients with Open-Angle Glaucoma or Ocular Hypertension
    Sarah L. Greig
    Emma D. Deeks
    Drugs & Aging, 2015, 32 : 251 - 260
  • [27] Short-term effect of latanoprost and timolol eye drops on tear fluid and the ocular surface in patients with primary open-angle glaucoma and ocular hypertension
    Thygesen, J
    Aaen, K
    Theodorsen, F
    Kessing, SV
    Prause, JU
    ACTA OPHTHALMOLOGICA SCANDINAVICA, 2000, 78 (01): : 37 - 41
  • [28] MICROCIRCULATION AND HEMODYNAMICS IN OCULAR HYPERTENSION AND PRIMARY OPEN-ANGLE GLAUCOMA
    ALEXEEV, BN
    SHMYREVA, VF
    MOSTOVOI, EN
    VESTNIK OFTALMOLOGII, 1986, (05) : 8 - 10
  • [29] Brinzolamide/Brimonidine: A Review of Its Use in Patients with Open-Angle Glaucoma or Ocular Hypertension
    Greig, Sarah L.
    Deeks, Emma D.
    DRUGS & AGING, 2015, 32 (03) : 251 - 260
  • [30] Brinzolamide 1%/timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study
    Altafini, Romeo
    Scherzer, Maria-Luise
    Hubatsch, Douglas A.
    Frezzotti, Paolo
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 2263 - 2270
12345